Pharmaceutical Market Europe • October 2020 • 3
COMMENT
As the world waits anxiously for a SARS-CoV-2 vaccine, there is another question to consider: will COVID-19 help or hinder the quest to increase uptake of other vaccinations? The current publicity campaign from pharmacies and even supermarkets emphasises that, even though our focus is squarely on the coronavirus, ‘regular’ flu still poses a very real danger.
As Rachel Howard says in her article on the importance of vaccinations on page 20: “To date, much of the media focus has been on seasonal influenza vaccines, but with prevention a hot topic more broadly, there is also the potential for manufacturers of vaccines against other diseases to tap in to this. Pneumococcal vaccines, in particular, could also be positioned as helping to avoid the dual burden of other respiratory infections and thus relieve pressure on healthcare systems strained by COVID-19.”
On a different note, in our cover feature by Chris Ross on communications excellence, he talks about mass media and says: “In the digital age, the average person is apparently exposed to between 6,000 and 10,000 promotional messages or branded items every day. Whether that’s via TV, print, digital platforms, social channels or mobile media, that’s quite an onslaught.”
He goes on to say that while communications excellence is a clichéd term, it’s never been more important. That’s certainly the case in pharma, where the challenge of getting high-cost medicines to patients is as much about effective communication as it is about scientific innovation. Read more about the importance of getting the basics right and staying focused on the customer on page 28.
I hope you enjoy this issue!
Iona Everson
Group Managing Editor
Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at www.pmlive.com/register
THE TEAM
Editorial:
Group Managing Editor
Iona Everson
Reporter
Lucy Parsons
Studio:
Executive Director
Karl Equi
Middleweight Graphic Designer
Helen Penfold
Sales:
Business Director
Tara Lovegrove
EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation
Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim
Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences
Stefan Janssens
President EMEA, Cegedim Dendrite
John Morris
Partner, KPMG
Paul Pay
Chief business development officer, Norgine
Mark Rothera
Chief executive officer, Orchard Therapeutics
Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals
PUBLISHED BY
PMGroup
Mansard House, Church Road, Little Bookham, Surrey, KT23 3JG, UK
Tel: +44 (0)1372 414200
Fax: +44 (0)1372 414201
CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com
Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.
© 2020 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.
The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW